Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: £1 M
• Last 3 months FTD volume: £28.81 M
• Last year FTD volume: £28.81 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	£37.13 M	£0.21 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	£3.25 M	£40.37 M	🇺🇸 USA
AbbVie ABBV	£50.09 M	£0.20 B	🇺🇸 USA
Illumina ILMN	£16.54 M	£66.14 M	🇺🇸 USA
Biogen BIIB	£36.5 M	£84.81 M	🇺🇸 USA
Pfizer PFE	£21.73 M	£0.33 B	🇺🇸 USA
Johnson & Johnson JNJ	£21.12 M	£0.32 B	🇺🇸 USA
Eli Lilly LLY	£85.36 M	£0.21 B	🇺🇸 USA
Merck MRK	£69.9 M	£0.12 B	🇺🇸 USA